Elizabeth joined Applied Silver in May 2016 and is responsible for leadership of the board of directors and CEO and effectively positioning the company with customers and partners to facilitate expansion of the business. Elizabeth has extensive experience bringing to market highly specialized genomic and healthcare related products. She serves as a director/chair on various boards (non-profit/public) and is a member of the National Association of Corporate Directors and Women Corporate Directors. Prior to joining Applied Silver, she was CEO/Director of NuGEN Technologies, Inc., VP Commercial – Americas and Pac Rim, for Tripos, Inc., and in senior commercial roles in North America and Europe for Affymetrix and Life Technologies. She received her BA in Chemistry from Michigan State University and an MS in Administration from Central Michigan University.
Co-Founder/CEO, Board Member
Sean is a co-inventor of Applied Silver’s SilvaClean® technology, which was developed while he was a student at Cal Poly. In 2010, Sean became CEO and has led the company through the initial SilvaClean product development to commercialization. He is responsible for implementing the overall strategy of the company, while meeting the needs of employees, investors, and customers. Sean graduated from California Polytechnic State University, San Luis Obispo and is an innovator with specialization in materials properties and aqueous chemistry.
Co-Founder and Board Member
Russ has been with Applied Silver since the company’s inception and has provided leadership in all aspects of the company’s evolution. He began his career with Intel in 1976 as one of the first 100 employees of the Systems Division. He was then recruited to join Sun Microsystems in 1982, where as a founding shareholder, he held many roles including the position of Vice President of Operations during the highest growth phase of the business. He served concurrently as a member of the Executive Committee and later became President of Sun Federal, a wholly-owned subsidiary that he founded to focus on sales to the CIA and NSA. Retiring from Sun, Russ joined the venture capital firm of Kleiner, Perkins, Caufield & Byers and served at several of their portfolio companies in the roles of corporate officer, CEO, and Board Member. Russ continues to pursue entrepreneurship working with both UCSB and Cal Poly where he has been a member of the President’s Cabinet Advisory Council for over a decade. He is a graduate of the California State Polytechnic College in San Luis Obispo, where as a student, he founded several startups businesses. After graduation from college, Russ enlisted in the Navy and later served in the U.S. Naval Air Reserve.
Jim is a longtime resident, community leader, and philanthropist of San Luis Obispo on the Central Coast of California. Jim began his entrepreneurial career in cooperation with his brother, by taking a single retail outlet in San Luis Obispo and building it into a 36-store sporting goods chain spanning four states. After selling the company, Jim’s attention turned to Copeland Properties, a major Central Coast commercial real estate development company. Jim’s commitment to the Central Coast extends beyond real estate into efforts aimed at improving the quality of life in the community, including projects such as the Cal Poly performing arts center, theatres, restaurants, and museums. Jim has served on the Dignity Health owned French Hospital Medical Center Community Board for over 10 years including as Chairman. A new Cardiac Care Center and Health Education Pavilion bear his name. The Pavilion is a joint effort with Cal Poly University to provide real-world exposure to students studying in medical-related fields.
Trygve is the founder and General Partner of T+T Holdings, LLC, a private investment company focused on private equity and hedge fund investments. He has served as the Chairman of Amkai, LLC and a Director of Sprout Pharmaceuticals, Inc., Slate Pharmaceuticals, Inc. and Diabetica Solutions Inc. Prior to founding T+T Holdings, Trygve was a Managing Director with Citigroup (2004-2007), Deutsche Bank (1999-2002), and Credit Suisse First Boston (1987-1999). His specialty as an investment banker was M&A advisory, primarily with a focus on health care. In addition to his advisory responsibilities, he has held several management positions including Head of US Healthcare at Credit Suisse First Boston, where he was also appointed to the Investment Banking Management Committee. Prior to investment banking, Trygve worked for McKinsey & Co. in Scandinavia. Trygve graduated cum laude with a BS from University of Utah, where he was an All-American skier, and he received an MBA with Honors from Columbia University.
A native of Detroit, Dick has been Chairman of the Board of Incyte Corporation since 2004. He was also a director of Ecolab, Inc. from February 2004 until May 2010 and a director of Varian, Inc. from 2001 until its acquisition by Agilent Technologies, Inc. in May 2010. He was Chairman and Chief Executive Officer of DuPont Pharmaceuticals Company, from July 2000 to October 2001. He served as Chief Administrative Officer of Pharmacia Corporation between April 2000 and July 2000. From January 1999 through March 2000, Dick served as Vice Chairman and Chief Administrative Officer of Monsanto Company, which he joined as a Process Design Engineer in 1964. He served as Chief Executive Officer of G.D. Searle & Co. from April 1995 to December 1998. He has also served as a Director of ING Group NV, General Binding Corp, Reliastar Insurance, Smith and Nephew pic and the MedPointe Company. Dick is also a director of several privately held companies. He holds a B.S. and M.S. degrees in Chemical Engineering from the University of Arizona and completed the Executive Management program at Columbia Business School.
Leo is a Research Scholar in Residence at Cal Poly and former President of the NorthShore University Health System Research Institute, the nation’s ninth largest comprehensive hospital based research program (NIH Funding). Prior to NorthShore, he was Dean of the College of Applied Health Sciences at the University of Illinois at Chicago. He has held over 50 national-level appointments and is a recognized authority on aging-related health policy, health promotion and disease prevention, and gerontology. A former Scholar in Residence at the Institute of Medicine, National Academy of Sciences (NAS), Leo has served as a member of its Committee on Health Promotion and Disability Prevention and the NAS/NRC Planning Committee on the National Information Infrastructure in Healthcare. He has held consultative appointments with numerous foundations including the Pew Charitable Trusts, The Kellogg Foundation, the Commonwealth Fund, and the Hartford Foundation. He received his MS from Duke University, Graduate Diploma (IGS) at Stockholm University, PhD from Texas A&M University, and MBA from Northwestern University – Kellogg School of Management.
Co-Founder, Head of Biochemistry
Bill joined Applied Silver in 2010, at the formation of the initial LLC of the business. He oversees chemistry/testing and quality control and plays a significant role in advising product development and commercialization. During his college/research career, Bill developed a textile coating using nanoparticle titanium dioxide. He also contributed to the development of a thermal degradation system for military safety equipment and an anti-scratch polyurethane based car paint. Bill is a graduate of California Polytechnic State University, San Luis Obispo.
Scott was a founder of Sun Microsystems in 1982 and assumed the role of CEO in 1984. In its first six years, Sun grew to over one billion dollars in annual revenue, attaining the status of the fastest growing company in the US from 1885-1989 and in 1995, it was voted one of the 100 best-managed companies in the US. In 2006, with revenues at $14 billion and nearly 38,000 employees, Scott relinquished the CEO title. Mr. McNealy continues to advise Fortune 500 companies and is Chairman of the B2B social networking company, Wayin. He has served on the boards of major multinational companies such as General Electric. Scott holds a BA from Harvard and an MBA from Stanford.
Trees is a board certified physician specializing in Infectious Diseases and Internal Medicine. He is the managing partner of Central Coast Infectious Diseases Consultants where he assists other physicians daily with challenging and complicated cases of patient infection. Trees is the Medical Director of the Infection Control Programs for five California Central Coast Hospitals (Sierra Vista Medical Center, Twin Cities Medical Center, Marian Medical Center, Arroyo Grande Community Hospital, and French Hospital Medical Center). He is trained and certified as a Hospital Epidemiologist by the CDC and the Society for Healthcare Epidemiology of America. In this role, he has oversight of the infection control programs at these 5 institutions and works closely with and provides guidance to other physicians, nursing staff, administrators, and infection control professionals. Trees also serves as the chairman of the Infectious Diseases Society of America (IDSA) Clinical Affairs Committee where he oversees a team that sets policy and assists members with many aspects of the clinical practice of Infectious Diseases. He is a Cal Poly Bio Science graduate where he later did graduate work prior to obtaining his medical degree from Western University of Health Sciences. Trees completed his Residency at Highland Hospital/UCSF and his subsequent training in Infectious Diseases at UC Davis in Sacramento, California.
John retired as partner of the law firm of Wilson Sonsini Goodrich & Rosati, where he practiced corporate, federal tax, securities and intellectual property law from 1970 until 2002. The firm has handled the IPOs for firms such as Apple, Sun, Google, and Tesla. From 2004 to 2009, John served as the CEO of MaxSP Corporation, an information technology services company. Since 1981, he has also served as a Director of Trimble Navigation (NASDAQ, TRMB), the pioneering commercial developer of the GPS. John currently serves on the Board of Directors of Tessera Technologies, Inc. (NASDAQ, TSRA), a developer of semiconductor packaging technology and the Fogarty Institute for Innovation, focused on medical products. He received a B.A. degree from Stanford University in 1963, a J.D. from the University of Southern California in 1966 and an L.L.M. in Taxation from New York University in 1970.
Greg is a Professor of Environmental Engineering at Carnegie Mellon University in Pittsburgh, PA and Deputy Director of the Center for Environmental Implications of Nanotechnology (CEINT). Greg conducts multidisciplinary laboratory and field research in the emerging field of environmental nanotechnology. His work is aimed at understanding how a nanomaterial’s properties affect their reactivity and fate in the environment, and how these properties map onto their potential for exposure risk. He also exploits the novel properties of nanomaterials to develop new technologies for environmental remediation. Greg teaches courses on physicochemical processes of organic chemicals in aquatic systems, environmental engineering, and environmental nanotechnology. He currently serves on the National Research Council committee to develop a federal research strategy for environmental health and safety research for engineered nano materials. He earned his Ph.D. from Stanford University.
Josh McQueen is the founder of McQueen, Mackin & Associates and the author of “Building Brand Trust: Discovering the Insights Behind Great Brands.” He served as the Executive Vice President and Director of Research and Planning Worldwide for agency powerhouse Leo Burnett, leading one of the largest agency planning, research and database teams. He later was a member of the private Worldwide Board of Leo Burnett, until it was acquired by Publicis, a publicly traded company. He serves on the editorial board of the Journal of Interactive Advertising and is a member of the board of Allendale Residential Homes for disadvantaged children. He was an Advertising Research Foundation Board member from 1988-1998, and a trustee with the Marketing Science Institute from 1986-1996. He is currently on the College of Media Leadership Council at the University of Illinois at Urbana-Champaign.
Sue Barnes, RN, BSN, CIC is a National Infection Prevention Consultant and previously was the National Program Leader for Infection Prevention and Control for Kaiser Permanente’s 7 regions, 35 hospitals and 431 medical offices since 1989. She is Board certified in Infection Control and Prevention and is a nationally recognized figure in the field of infection prevention. In 2013 she established a national Corporate Director’s group and coordinates meetings and communication among the members. Sue participated in the development of the APIC Guide to Elimination of CRBSI, APIC Guide to the Elimination of Infections in Hemodialysis, and APIC Training Program for Infection Prevention in Ambulatory Care. She is the author of the KP HAI Prevention Plus Measures toolkit and is a subject matter expert consultant on HAIs. Speaking engagements have included the AORN Congress 2013, APIC Conference 2012, 2013, Decennial Conference 2012, numerous local, national APIC and national KP web presentations. Presentation topics have included SSI (surgical site infection) prevention, CDI (Clostridium difficile) prevention, IP mentoring, Scope reprocessing, Hand Hygiene, Vascular Access and CLABSI (central line associated bloodstream infection) prevention, simulation as a method of teaching infection prevention principles. In addition Sue has been published in journals including AORN Journal, American Journal of Infection Control, The Joint Commission Source for Compliance Strategies and The Permanente Journal. She served on the National APIC Board of Directors from 2010 to 2012, and was selected to represent APIC on the TAP (technical advisory panel) of the National Quality Forum (NQF) on Healthcare Associated Infections (HAI) and the NQF ESRD Steering Committee. She is currently (2014 – 2015) is President of the SFBA APIC chapter and Secretary for the California APIC Coordinating Council.